Skip to search formSkip to main contentSkip to account menu

docetaxel Injection [Taxotere]

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The present work focuses on design and development of surface functionalized LCNPs for improving tumor delivery of DTX… 
Highly Cited
2014
Highly Cited
2014
Docetaxel is a potent anticancer drug, but development of an oral formulation has been hindered mainly due to its poor oral… 
Highly Cited
2013
Highly Cited
2013
The aim of the present study was to prepare, characterize, and evaluate solid lipid nanoparticles (SLNs) containing docetaxel… 
Highly Cited
2010
Highly Cited
2010
Three types of nanoparticle formulation from biodegradable PLGA-TPGS random copolymer were developed in this research for oral… 
Highly Cited
2004
Highly Cited
2004
The lipogenic enzyme fatty acid synthase (FAS) is differentially overexpressed and hyperactivated in a biologically aggressive… 
Highly Cited
2003
Highly Cited
2003
Docetaxel (Taxotere®), alone or in combination with other anticancer agents, has proven efficacy in the first- and second-line…